Total buying$00 buys
TLSI
TriSalus Life Sciences, Inc.
NasdaqHealthcareSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Insider activity for last month from 10/03 to 11/03.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$4.11k3 sells
Net open-market−$4.11kBuying minus selling
Active insiders4Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 07, 2026
Open-market transaction mix · 3 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Oct 2026 | 0 | 3 | 0 | $0 | $4.11k | -$4.11k |
| Nov 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (4)Oct 2026Nov 2026
Largest insider activity
By absolute net disclosed value · current transaction page- ST-$11.8k
- MR-$1.4k
- SJ-$1.4k
- CF-$1.3k
TLSI transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
TLSITriSalus Life Sciences, Inc. | Cox Bryan F.CR | S · saleSEC filing ↗ | -$1.29kView disclosure → | |
TLSITriSalus Life Sciences, Inc. | Marshak RichardCCO | S · saleSEC filing ↗ | -$1.42kView disclosure → | |
TLSITriSalus Life Sciences, Inc. | Stevens JenniferCRO | S · saleSEC filing ↗ | -$1.38kView disclosure → | |
TLSITriSalus Life Sciences, Inc. | Szela Mary TCEO · PRES | F · withholdingSEC filing ↗ | -$11.7kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Recent filing activity
Most recent 4 transactions on this page · color = transaction codeFiling detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period4transactionstxns
- S · Open-market sells · dominant3 · 75%
- F · Tax withholding1 · 25%
Activity by reported role
A joint filing can contribute to multiple rolesCCO1
Chief executive officer1
CR1
CRO1
PRES1
Reported Holdings After
Separated by insider, security, and ownership type
Szela Mary TCommon Stock · Direct
1,074,990Oct 05, 2026
Stevens JenniferCommon Stock · Direct
123,794Oct 05, 2026
Marshak RichardCommon Stock · Direct
127,994Oct 05, 2026
Cox Bryan F.Common Stock · Direct
162,805Oct 05, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redOct 03 → Nov 03
LessMore
TriSalus Life Sciences, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at TriSalus Life Sciences, Inc.?
Cox Bryan F., Marshak Richard, Stevens Jennifer, Szela Mary T.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Cox Bryan F. reported a sale on Oct 05, 2026 valued at $1.29k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $4,113.43. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.